Literature DB >> 12045092

V(D)J recombination: RAG proteins, repair factors, and regulation.

Martin Gellert1.   

Abstract

V(D)J recombination is the specialized DNA rearrangement used by cells of the immune system to assemble immunoglobulin and T-cell receptor genes from the preexisting gene segments. Because there is a large choice of segments to join, this process accounts for much of the diversity of the immune response. Recombination is initiated by the lymphoid-specific RAG1 and RAG2 proteins, which cooperate to make double-strand breaks at specific recognition sequences (recombination signal sequences, RSSs). The neighboring coding DNA is converted to a hairpin during breakage. Broken ends are then processed and joined with the help of several factors also involved in repair of radiation-damaged DNA, including the DNA-dependent protein kinase (DNA-PK) and the Ku, Artemis, DNA ligase IV, and Xrcc4 proteins, and possibly histone H2AX and the Mre11/Rad50/Nbs1 complex. There may be other factors not yet known. V(D)J recombination is strongly regulated by limiting access to RSS sites within chromatin, so that particular sites are available only in certain cell types and developmental stages. The roles of enhancers, histone acetylation, and chromatin remodeling factors in controlling accessibility are discussed. The RAG proteins are also capable of transposing RSS-ended fragments into new DNA sites. This transposition helps to explain the mechanism of RAG action and supports earlier proposals that V(D)J recombination evolved from an ancient mobile DNA element.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12045092     DOI: 10.1146/annurev.biochem.71.090501.150203

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  287 in total

1.  The RAG1 N-terminal domain is an E3 ubiquitin ligase.

Authors:  Vyacheslav Yurchenko; Zhu Xue; Moshe Sadofsky
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

2.  Regulation of RAG1/RAG2-mediated transposition by GTP and the C-terminal region of RAG2.

Authors:  Chia-Lun Tsai; David G Schatz
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

3.  The C-terminal portion of RAG2 protects against transposition in vitro.

Authors:  Sheryl K Elkin; Adam G Matthews; Marjorie A Oettinger
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

4.  Inverse transposition by the RAG1 and RAG2 proteins: role reversal of donor and target DNA.

Authors:  I-hung Shih; Meni Melek; Nadeesha D Jayaratne; Martin Gellert
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

5.  DNA mismatches and GC-rich motifs target transposition by the RAG1/RAG2 transposase.

Authors:  Chia-Lun Tsai; Monalisa Chatterji; David G Schatz
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

6.  Integrated signaling in developing lymphocytes: the role of DNA damage responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

7.  A non-sequence-specific DNA binding mode of RAG1 is inhibited by RAG2.

Authors:  Shuying Zhao; Lori M Gwyn; Pallabi De; Karla K Rodgers
Journal:  J Mol Biol       Date:  2009-02-20       Impact factor: 5.469

8.  Polymerase mu is a DNA-directed DNA/RNA polymerase.

Authors:  Stephanie A Nick McElhinny; Dale A Ramsden
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  p53 Deficiency rescues neuronal apoptosis but not differentiation in DNA polymerase beta-deficient mice.

Authors:  Noriyuki Sugo; Naoko Niimi; Yasuaki Aratani; Keiko Takiguchi-Hayashi; Hideki Koyama
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Functional overlap in the cis-acting regulation of the V(D)J recombination at the TCRbeta locus.

Authors:  Bernard Khor; Grace K Mahowald; Katrina Khor; Barry P Sleckman
Journal:  Mol Immunol       Date:  2008-12-13       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.